In 2015, Medicare spent about $26 billion on Part B drugs, including injectable drugs, and certain cancer drugs, which are typically administered in a physician's office or hospital outpatient department. GAO was asked to examine Medicare's share of the Part B drug market. This report describes Medicare's market share for high-expenditure Part B drugs paid based on ASP and the characteristics of those drugs...
MEDICARE PART B: Medicare Represented at Least Half of the Market for 22 of the 84 Most Expensive Drugs in 2015
MEDICARE PART B: Medicare Represented at Least Half of the Market for 22 of the 84 Most Expensive Drugs in 2015
Livre numérique Kobo
Prix habituel
$30.14
Prix promotionnel
$30.14
Prix habituel
$0.00
Prix unitaire
par
Lisez ce titre à l’aide de l’une des applications ou des appareils Kobo suivants :
Ordinateur
Liseuse
Tablette
Android
iOS
Aperçu
Sélectionnez une option de livraison
MEDICARE PART B: Medicare Represented at Least Half of the Market for 22 of the 84 Most Expensive Drugs in 2015
Livre numérique Kobo
$30.14
1 Item ajouté au panier 1 Item ajouté au ramassage
MEDICARE PART B: Medicare Represented at Least Half of the Market for 22 of the 84 Most Expensive Drugs in 2015
Livre numérique Kobo
$30.14
